Risk Factors of Cardiovascular Pathology in Patients with Gout

被引:2
|
作者
Khituova, Lidiya [1 ]
Khabizhanova, Venera [2 ]
Musayev, Abdugani [3 ]
Akhmetova, Gulsim [3 ]
Almukhambetova, Elmira [3 ]
Indershiyev, Vildan [4 ]
机构
[1] Kazakh Natl Med Univ, Dept Child Dis, Alma Ata, Kazakhstan
[2] Kazakh Natl Med Univ, Dept Gen Med Practice, Alma Ata, Kazakhstan
[3] Kazakh Natl Med Univ, Dept Ambulance & Emergency Care, Alma Ata, Kazakhstan
[4] Kazakh Natl Med Univ, Dept Family Med, Alma Ata, Kazakhstan
关键词
Gout risk factors; cardiovascular pathology; cardiovascular risk; rheumatology; hyperuricemia; cardiovascular diseases (CVD); MANAGEMENT; HYPERURICEMIA; CARE;
D O I
10.2174/1573397118666220802141420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the frequency and assess the risk of cardiovascular disease in patients suffering from gout. Background Gout is a sign of disturbed metabolism, which is associated with cardiovascular diseases (CVD). Soaring mortality is associated with a lot of risk factors and comorbid conditions, which have to be dealt with the help of scientists and practitioners. Methods The following retrospective study included 218 patients suffering from gout according to the criteria of S.L. Wallace. The risk of major coronary events was calculated via the SCORE scale. Results Arterial hypertension and BMI > 25 kg / m2 (90.8%) have prevailed among the respondents. Increased level of total cholesterol (TC) was detected in 63.8% cases, decreased level of high-density lipoproteins - in 71.6%, and hypertriglyceridemia - in 60.5% relevantly. 175 patients (80.3%) had high cardiovascular risk (estimated more than 5%). 43 (19.7%) of them had a low and medium risk of developing fatal CVD (1-4%). The high share of patients suffering from gout was endangered with cardiovascular pathology. Conclusion The most frequently matched risk factors among patients suffering from gout are an increase in BMI> 25 kg/m2 (90.8%) and dyslipidemia.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 50 条
  • [31] Diagnosis of Gout as a Correlative Risk for Acute Myocardial Infarction in the Absence of Traditional Cardiovascular Risk Factors
    Munshi, Rezwan F.
    Pellegrini, Jr James R.
    Olson, Samuel
    Sodoma, Andrej M.
    Anand, Prachi
    Hai, Ofek
    Zeltser, Roman
    Makaryus, Amgad N.
    SOUTHERN MEDICAL JOURNAL, 2024, 117 (09) : 539 - 542
  • [32] Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout
    Slot, Ole
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 457 - 457
  • [33] Allopurinol Use and the Risk of Acute Cardiovascular Events in Patients with Gout and Diabetes
    Singh, Jasvinder A.
    Ramachandaran, Rekha
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] Cardiovascular risk in gout: time for action
    Abhishek, Abhishek
    Cipolletta, Edoardo
    LANCET RHEUMATOLOGY, 2024, 6 (03): : e131 - e132
  • [35] Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
    Singh, Jasvinder A.
    Ramachandaran, Rekha
    Yu, Shaohua
    Curtis, Jeffrey R.
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [36] Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
    Kang, Eun Ha
    Park, Eun Hye
    Shin, Anna
    Song, Jung Soo
    Kim, Seoyoung C.
    EUROPEAN HEART JOURNAL, 2021, 42 (44) : 4578 - +
  • [37] CRP, but not ESR, associated with disease severity and cardiovascular risk in patients with gout
    Ilinykh, E. V.
    Barskova, V. G.
    Alexandrova, E. N.
    Novikov, A. A.
    Nassonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 433 - 434
  • [38] Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease
    Smiyan, S. I.
    Danchak, S. V.
    PATHOLOGIA, 2015, (03): : 36 - 40
  • [39] Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
    Jasvinder A. Singh
    Rekha Ramachandaran
    Shaohua Yu
    Jeffrey R. Curtis
    BMC Cardiovascular Disorders, 17
  • [40] CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH PSYCHOSIS
    Eriksson, Sven V.
    OSby, U.
    Edman, G.
    Mannelid, D.
    Akselson, S.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 51 - 51